- ASSISTANT PROFESSOR Psychiatry
Psychiatry, American Board of Psychiatry and Neurology
MD, Mount Sinai School of Medicine
Residency, Internal Medicine
Mount Sinai Hospital
Yale Psychiatric Institute
Fellowship, Geriatric Psychiatry
Mount Sinai Hospital
Dr. Neugroschl is a 1988 graduate of Mount Sinai School of Medicine. After graduation Dr. Neugroschl was a Medical Intern at Mount Sinai School of Medicine, a psychiatry Resident at Yale University and then a Geriatric Psychiatry Fellow at Mount Sinai. For ten years she was the director of the geriatric psychiatry clinic, and was also the Director of the Geriatric Psychiatry Fellowship and Medical Student Education in Psychiatry. In 2009 she decided to turn her skills and interests to Alzheimer’s research, and has submitted a project looking at patient reported outcomes in Alzheimers disease. She is currently Co-director of the Education and Information Transfer Core of Mount Sinai’s Alzheimer’s Disease Research Center.
Geriatric Psychiatry Education
Nancy Roeske Certificate of Recognition for Excellence in Medical Student Education
American Psychiatric Association
Neugroschl J, Sano M. Current Treatment and Recent Research in Alzheimer Disease. Mount Sinai Journal of Medicine 2010 Jan; 77(1): 3-16.
Neugroschl J, Sano M. An Update on Treatment and Prevention Strategies for Alzheimer Disease. Current Neurology and Neuroscience Reports 2009 Sep; 9(5): 368-76.
Kalapatapu R, Neugroschl J. Update on neuropsychiatric symptoms of dementia: evaluation and management. Geriatrics 2009 Apr; 64(4): 20-6.
Dugue M, Neugroschl J, Sewell M, Marin D. Review of dementia. Mt Sinai J Med 2003 Jan; 70(1): 45-53.
Neugroschl J, Davis KL. Peripheral Markers in Alzheimer's disease. Am J Geriatr Psychiatry 2002 Nov-Dec; 10(6): 660-667.
Dugue M, Neugroschl J. Anxiety disorders. Helping patients regain stability and calm. Geriatrics 2002 Aug; 57(8): 27-31.
Neugroschl J. Agitation. How to manage behavior disturbances in the older patient with dementia.. Geriatrics 2002 Apr; 57(4): 33-7.
Carney MT, Neugroschl J, Morrison RS, Marin D, Siu AL. The development and piloting of a capacity assessment tool. J Clin Ethics 2001 Spring; 12(1): 17-23.
Marin DB, Dugue M, Schmeidler J, Santoro J, Neugroschl J, Zaklad G, Brickman A, Schnur E, Hoblyn J, Davis KL. The caregiver activity survey (CAS): longitudinal validation of an instrument that measures time spent caregiving for individuals with Alzheimer's disease. Int J Geriatr Psychiatry 2000 Aug; 15(8): 680-686.
Marin DB, Rubin E, Fox B, Neugroschl J. Feasibility of a Healthcare Proxy Counseling Program for Patients with Alzheimer's disease. Journal of Palliative Medicine 1999; 2: 323-329.
Dugue M, Neugroschl J. Anxiety Disorders in the Elderly. Geriatrics 2002 Aug; 57(8): 27-31.
Neugroschl J. The management of Agitation in Dementia. Geristrics 2002 Apr; 57(4): 33-37.
Hoblyn J, Neugroschl J, Caughey A, editors. Blueprints: Clinical Cases in Psychiatry. Blackwell Science; 2002.
McParland E, Neugroschl J, Marin D. Women as Caregivers. In: Psychiatric Illness and Women: Emerging Treatment and Research
Women as Caregivers. 1st American Psychiatric Press; 2002.
Neugroschl J, Hoblyn J, del Castillo C, Caughey A, editors. Blueprints: Notes & Cases - Behavioral Science and Epidemiology. Blackwell Science; 2003.
- The TOMMORROW Study: A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment due to Alzheimer's Disease (MCI due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD-4833 SR 0.8 mg QD) to Delay the Onset of MCI due to AD in Cognitively Normal Subjects
- A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild to Moderate Alzheimer's Disease (EPOCH)
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Neugroschl did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
5 East 98th Street Floor 1 Room 1 A LEFT - ADRC
New York, NY 10029
1425 Madison Avenue
New York, NY 10029